Biodesix (BDSX) Current Assets (2019 - 2026)

Biodesix (BDSX) has 8 years of Current Assets data on file, last reported at $40.9 million in Q1 2026.

• Quarterly Current Assets rose 38.11% year-over-year to $40.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.9 million (up 38.11% YoY) and the FY2025 annual result came in at $32.5 million, down 17.64% from the prior year.
• Current Assets improved to $40.9 million in Q1 2026, from $32.5 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $57.6 million in Q2 2024 to a low of $24.1 million in Q3 2022.
• A 5-year average of $35.7 million and a median of $33.4 million in 2025 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets tumbled 66.48% — and 2024, when it soared 128.08%.
• Tracing BDSX's Current Assets over 5 years: stood at $53.3 million in 2022, then declined by 25.6% to $39.7 million in 2023, then slipped by 0.5% to $39.5 million in 2024, then declined by 17.64% to $32.5 million in 2025, then climbed by 25.81% to $40.9 million in 2026.
• The last three Current Assets figures came in at $40.9 million (Q1 2026), $32.5 million (Q4 2025), and $33.4 million (Q3 2025), per Business Quant data.